Home Forums Marketplace Table of Contents Events Member List Site Map Register Mark Forums Read



Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.


Ossulin? Oral Insulin Data To Be Presented At The San Francisco Diabetes Congress On November 6, 2009

Reply
Submit Thread >  Submit to Digg Submit to Reddit Submit to Furl Submit to Del.icio.us Submit to Google Submit to Yahoo! This Submit to Technorati Submit to StumbleUpon Submit to Spurl Submit to Netscape  < Submit Thread
 
Thread Tools Display Modes
  #1  
Old 6th November 2009, 05:20 PM
RSSFeedBot RSSFeedBot is offline
I, Robot
 
About:
Join Date: Jul 2008
Posts: 3,061
Join Date: Jul 2008
Marketplace reputation 0% (0)
CPD Points: 1
Thanks: 0
Thanked 5 Times in 5 Posts
Default Ossulin? Oral Insulin Data To Be Presented At The San Francisco Diabetes Congress On November 6, 2009

Podiatry Arena members do not see these ads
The first public data on Ossulin? a new oral insulin product, will be presented today at the 9th Annual Diabetes Technology Meeting in San Francisco, CA. Ossulin? is being developed by Puredel Limited, a joint-venture between the European pharmaceutical specialty company CM&D Pharma Limited and Natreon Inc., New Brunswick, NJ., developers of the proprietary delivery platform (

More...
Reply With Quote
Sponsored Links
Reply



Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
vB code is On
Smilies are On
[IMG] code is On
HTML code is On
Forum Jump

Translate This Page

Similar Threads
Thread Thread Starter Forum Replies Last Post
Updated Data From Randomized Controlled Phase II Study Evaluating Oral Apremilast In Psoriatic Arthritis Demonstrates Sustained Response At Six Months RSSFeedBot Latest Rheumatology News 0 21st October 2009 01:40 AM
New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions RSSFeedBot Latest Diabetes Medicine Research & News 0 16th October 2009 07:30 AM
Treatment With Insulin Or Metformin Does Not Reduce Inflammatory Biomarkers For Patients With Diabetes RSSFeedBot Latest Diabetes Medicine Research & News 0 17th September 2009 03:20 AM
Diabetes Advance: Researchers Find Gene That Causes Resistance To Insulin RSSFeedBot Latest Diabetes Medicine Research & News 0 6th September 2009 09:10 PM
Oral prednisolone is more cost-effective than oral indomethacin for acute gout RSSFeedBot Gout Online 0 13th June 2009 10:31 PM


New To Site? Need Help?

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.


All times are GMT -7. The time now is 04:12 PM.